Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque

Objective To understand the determinants of troponin release in patients with stable coronary artery disease (CAD) by comparing high sensitive troponin T (hsTnT) levels with computed tomography angiography (CTA) characteristics of atherosclerotic plaque. Methods hsTnT was determined in 124 consecutive patients with stable angina, who underwent clinically indicated 256-slice CTA for suspected CAD. CTA was used to assess (1) coronary calcification; (2) stenosis severity; (3) non-calcified plaque volume; (4) plaque composition (soft or mixed, described as ‘non-calcified’ versus calcified) and (5) the presence of vascular remodeling in areas of non-calcified plaque. Results All CT scans were performed without adverse events, and diagnostic image quality was achieved in 1830/1848 available coronary segments (99.0%). In 29/124 patients, hsTnT was ≥14 pg/ml (range 14.0–34.4). Weak, albeit significant, correlations were found between hsTnT and calcium scoring (r=0.45, p<0.001), while a stronger correlation was found between hsTnT and the total non-calcified plaque burden (r=0.79, p<0.001). Patients with non-calcified plaque (n=44) yielded significantly higher hsTnT values than those with normal vessels (n=46) or those with only calcified lesions (n=26), (12.6±5.2 vs 8.3±2.6 and 8.8±3.0 pg/ml, respectively, p<0.001). Furthermore, those with remodeled non-calcified plaque (n=8) showed even higher hsTnT values of 26.3±6.5 pg/ml than all other groups (p<0.001). This allowed the identification of patients with remodeled non-calcified plaque by hsTnT with high accuracy (area under the curve=0.90, SE=0.07, 95% CI 0.84 to 0.95). Conclusions Chronic clinically silent rupture of non-calcified plaque with subsequent microembolisation may be a potential source of troponin elevation. In light of recent imaging studies, in which patients with positively remodeled non-calcified plaque were shown to be at high risk for developing acute coronary syndromes, hsTnT may serve as a biomarker for such ‘vulnerable’ coronary lesions even in presumably stable CAD.

[1]  H. Kauczor,et al.  Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography , 2010, European Radiology.

[2]  R. Detrano,et al.  Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. , 2010, Atherosclerosis.

[3]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[4]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[5]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[6]  A. Wu,et al.  Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study. , 2009, American heart journal.

[7]  Bernhard Bischoff,et al.  Impact of a reduced tube voltage on CT angiography and radiation dose: results of the PROTECTION I study. , 2009, JACC. Cardiovascular imaging.

[8]  R. Virmani,et al.  Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. , 2009, Journal of the American College of Cardiology.

[9]  L. Lind,et al.  Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. , 2008, European heart journal.

[10]  H. Katus,et al.  Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. , 2008, Clinical chemistry.

[11]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[12]  L. Wallentin,et al.  Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality , 2007, Circulation.

[13]  Gabriel P Krestin,et al.  64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. , 2007, Journal of the American College of Cardiology.

[14]  J. Cohn,et al.  Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure , 2007, Circulation.

[15]  A. Jaffe,et al.  Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. , 2007, The American journal of cardiology.

[16]  Hirofumi Anno,et al.  Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.

[17]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[18]  A. Khera,et al.  Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.

[19]  P. Venge,et al.  Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study , 2006, Circulation.

[20]  A. Jeremias,et al.  Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded , 2005, Annals of Internal Medicine.

[21]  H. Katus,et al.  Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. , 2004, The American journal of cardiology.

[22]  G. Heusch.  Coronary microembolization*1 , 2004 .

[23]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[24]  J. P. Higgins,et al.  Elevation of cardiac troponin I indicates more than myocardial ischemia. , 2003, Clinical and investigative medicine. Medecine clinique et experimentale.

[25]  E. Braunwald,et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.

[26]  P. O'Malley,et al.  C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. , 2001, American heart journal.

[27]  M J Davies,et al.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption , 1999, Heart.

[28]  C. Heeschen,et al.  Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. , 1999, The New England journal of medicine.

[29]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[30]  P. Serruys,et al.  Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. , 1995, Circulation.

[31]  Robert Califf,et al.  Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[32]  A. Remppis,et al.  Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction , 1991, Circulation.

[33]  A. Remppis,et al.  Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. , 1989, Journal of molecular and cellular cardiology.

[34]  G. Diamond.  A clinically relevant classification of chest discomfort. , 1983, Journal of the American College of Cardiology.

[35]  Lars Lind,et al.  Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. , 2009, Clinical chemistry.

[36]  Udo Hoffmann,et al.  Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. , 2007, Atherosclerosis.

[37]  R. Erbel,et al.  Coronary microembolization. , 2001, Progress in cardiovascular diseases.